Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jesús Gabriel Sánchez-Ramos"'
Autor:
Celia Castaño-Amores, Xando Díaz-Villamarín, Ana María Pérez-Gutiérrez, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, Eduardo Moreno-Escobar, Jesús Gabriel Sánchez-Ramos, Luis Javier Martínez-González, Cristina Lucía Dávila-Fajardo
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112069- (2021)
β-blockers are commonly prescribed to treat multiple cardiovascular (CV) diseases, but, frequently, adverse drug reactions and intolerance limit their use in clinical practice. Interindividual variability in response to β-blockers may be explained
Externí odkaz:
https://doaj.org/article/0ba69934c5aa43c2abc32f21463e8fbc
Autor:
Athanassios Vozikis, Jesús Gabriel Sánchez Ramos, Theodora Katsila, Christina Mitropoulou, Marina Bartsakoulia, Konstantina Chalikiopoulou, Xando Díaz-Villamarín, Anne John, Bassam R. Ali, Konstantina Kehagia, Efthymios Skoufas, Sarah Wordsworth, Maria Gkotsi, Luis Javier Martinez-Gonzalez, Vasilios Fragoulakis, George P. Patrinos, Eva Katrali, Cristina Lucía Dávila-Fajardo
Publikováno v:
The pharmacogenomics journal. 19(5)
Clopidogrel is an antiplatelet drug given to patients before and after having a percutaneous coronary intervention (PCI). Genomic variants in the CYP2C19 gene are associated with variable enzyme activities affecting drug metabolism and hence, patient
Autor:
José Cabeza Barrera, Eduardo Moreno Escobar, Juan J. Fernández, Cristina Lucía Dávila-Fajardo, Concepción Correa, María J. Soto Pino, Jesús Gabriel Sánchez Ramos, Luis Javier Martinez-Gonzalez, Celia Gómez Peña, Isabel Blancas, Dámaso Fernández, Pedro Carmona-Sáez
Publikováno v:
Pharmacogenetics and genomics. 25(8)
The HER2 655 AG genetic variant has recently been associated with trastuzumab-induced cardiotoxicity in HER2 breast cancer patients. Considering previous results, the aim of our study was to validate the role of this polymorphism as a predictor of th